GlassScriptPhysician profile
Nabeel A Khan
NPI 1265647150
$7,275.39
in general payments reported to CMS, 2019-2025
19 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $1,160 · 2021: $1,237 · 2022: $4,042 · 2023: $191 · 2024: $200 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551 · Long Term Medical Supply Or Device Loan: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.81 |
| Long Term Medical Supply Or Device Loan | $132.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $5,698.83 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $361.99 | 2019-2022 | |
| Abbvie INC. | $253.80 | 2023-2025 | |
| Smith+Nephew, INC. | $228.80 | 2022-2025 | Grafix Pl, Renasys Touch, Pico |
| Integra Lifesciences Corporation | $223.54 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $196.44 | 2019-2022 | |
| Novo Nordisk INC | $72.61 | 2024 | |
| Galderma Laboratories, L.P. | $28.63 | 2022 | |
| Celgene Corporation | $27.07 | 2019 | |
| Mentor Worldwide LLC | $26.47 | 2019 | |
| Tesaro, INC. | $20.44 | 2019 | |
| Stryker Corporation | $19.52 | 2024 | Swanson |
| Bioventus LLC | $18.52 | 2022 | |
| Kci USA, INC. | $18.49 | 2023 | Prevena |
| Bayer Healthcare Pharmaceuticals INC. | $17.90 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $16.65 | 2019 | |
| Medtronic, INC. | $16.17 | 2024 | V-Loc 180 |
| Lilly USA, LLC | $14.90 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabeel Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.